s

Live Webinar

HIPAA: Avoid Costly Penalties and Violations Against Your Clinical Research - April 25th @ 1pm ET

$167.00

Live Webinar

HIPAA: Avoid Costly Penalties and Violations Against Your Clinical Research - April 25th @ 1pm ET

$167.00

Choose Your Format:
  •  In 2018, The University of Texas MD Anderson Cancer Center paid 4.3 million dollars for HIPAA violations. In 2016, the Feinstein Institute for Medical Research paid 3.9 million dollars for HIPAA Privacy and Security Rule violations.

    These are just two examples of what could happen to you if your protected health information (PHI) is not securely handled. These penalties not only affect your research, but your institution will certainly not be happy that they are on the hook for fines associated with your HIPAA violations, not to mention the lawsuits from research participants with compromised PHI.
    During the upcoming training from attorney and HIPAA expert, Heidi Kocher, JD, on Thursday, April 25th at 1 pm ET, you will be provided with a step-by-step breakdown of HIPAA regulations so that you know how to protect yourself and the research participants involved in your study.

     


    100% Satisfaction Guaranteed or a Full Refund.

    You take no risk whatsoever. If you find this essential session doesn't meet your expectations or you are not satisfied for any reason, simply let us know.

  • Here are a few of the clinical research HIPAA protection strategies that will you will walk away with by attending this upcoming, 60-minute online training:

      • Clearly determine which clinical projects MUST comply with HIPAA to protect yourself and your institution
      • Learn numerous PHI Identifiers to make sure that you know what information must be protected
      • Master the elements of authorization that are required to allow disclosure of PHI
      • Effectively interact with clinical subjects to securely receive PHI and patient authorization
      • Communicate patient informed consent more effectively and compliantly
      • Quickly determine when patient authorization is and is not required
      • And so much more…

    Who Should Attend: This training will benefit ALL researchers with access to PHI. This includes academic researchers and medical doctors involved in clinical research.

    Your protocols and your methods regarding clinical research must be compliant with the rules and regulations required by HIPAA. If not, it can cost you millions of dollars in fines, and your research career may never recover.

    If you do not protect PHI, you put not only your research, but your institution at risk. Don’t wait, register for this training today and make sure that you are HIPAA compliant, which will help you maximize your research’s success and impact.


    100% Satisfaction Guaranteed or a Full Refund.

    You take no risk whatsoever. If you find this essential session doesn't meet your expectations or you are not satisfied for any reason, simply let us know.

  • Meet Your Expert: Heidi Kocher

    Heidi Kocher has 20 years of experience in legal and compliance issues related to healthcare. Her experience includes positions at a large hospital corporation, serving as a compliance officer for a sleep lab/DME company and a compliance director, chief privacy officer and interim chief compliance officer at a medical device manufacturer. In addition, she has represented and advised critical access and long-term care hospitals, physician groups, home health agencies, DME companies, pharmacies (including compounding pharmacies), non-profit organizations and licensed individuals.

    She is an expert in all aspects of compliance and privacy programs, including developing and deploying policies, procedures and training. Her experience includes implementing the various requirements and aspects of a Corporate Integrity Agreement, responding to and defending audits from Medicare, Medicaid and private insurers up through the ALJ level, guiding clients through voluntary self-disclosures, seeking advisory opinions from the OIG, and defending FDA audits. As a result, she understands the complexities and challenges that providers large and small face in complying with increasingly varied and complex laws.